Electro-Acupuncture for Bladder Pain Syndrome: A Protocol of a Randomized Controlled Trial and Study for Central Mechanism
Yunyun Xu,Yangyun Chen,Yan Shi,Jianhua Lu,Zonglin Wu,Zhe Liu,Yuerong Chen,Wenqin Ni,Qike Ding,Wei Dai,Xinyuan Wu,Jianqiao Fang,Yuanyuan Wu
DOI: https://doi.org/10.2147/JPR.S370751
IF: 2.8319
2022-07-13
Journal of Pain Research
Abstract:Yunyun Xu, 1, &ast Yangyun Chen, 1, &ast Yan Shi, 2 Jianhua Lu, 3 Zonglin Wu, 1 Zhe Liu, 1 Yuerong Chen, 1 Wenqin Ni, 1 Qike Ding, 4 Wei Dai, 4 Xinyuan Wu, 4 Jianqiao Fang, 1 Yuanyuan Wu 5 1 The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou City, Zhejiang Province, People's Republic of China; 2 Department of Acupuncture & Tuina, Hangzhou First People's Hospital, Hang Zhou City, Zhejiang Province, People's Republic of China; 3 Department of Acupuncture & Moxibustion, Mishi Xiang Community Health Service Center, Hang Zhou City, Zhejiang Province, People's Republic of China; 4 The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou City, Zhejiang Province, People's Republic of China; 5 Department of Acupuncture & Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hang Zhou City, Zhejiang Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuanyuan Wu, Email Objective: The efficacy of conventional treatments for treating bladder pain syndrome (BPS) remains unsatisfactory. Electro-acupuncture (EA) is one of the complementary treatments with great analgesic effect and minimal side effect, but evidence of the efficacy of EA on BPS is limited. Thus, this study aims to investigate the efficacy and safety of EA for treating BPS and study on central mechanism of patients with BPS. Methods/Design: The study is a randomized controlled and assessor-blinded design trial. A total of 84 participants will be randomly assigned to medication group (n=21), EA group (n=42) and sham electro-acupuncture (SA) group (n=21) in a 1:2:1 allocation ratio. This trial will include baseline period, 4-week treatment period and 4-week follow-up period. Participants in medication group will undergo treatment of amitriptyline for a period of 4 weeks. Participants in EA and SA groups will receive a 30 min EA or SA treatment for a total of 12 sessions over 4 weeks. The primary outcome is the Visual Analog Scale (VAS). The secondary outcomes include the O'Leary-Sant questionnaire, 24-hour voiding diary, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD) and functional magnetic resonance imaging (fMRI). The VAS will be collected at baseline, week 2, week 4, and week 8 after randomization. The O'Leary-Sant questionnaire, HAMA and HAMD will be assessed at baseline, week 4 and week 8 after randomization. The 24-hour voiding diary will be assessed every single day. The fMRI data will be collected at baseline and week 4. Discussion: The results will provide evidence on the efficacy and safety of EA in the management of BPS and investigate the central mechanism of EA in treating patients with BPS. Trial Registration: ClinicalTrials.gov identifier: NCT05279963. Registered on 15 March 2022. Keywords: electro-acupuncture, bladder pain syndrome, randomized controlled trial, functional magnetic resonance imaging Bladder pain syndrome (BPS) is a chronic, nonbacterial cystitis characterized by persistent or recurrent pain, pressure or discomfort in the bladder region associated with lower urinary tract symptoms of more than 6 weeks duration. 1 It usually occurs in middle-aged women and is characterized by fibrotic of the bladder wall accompanied by a reduction in bladder volume. 2 The prevalence of BPS in previous reports ranges from 10 to 510 per 100,000. 3–5 In addition, because of its delayed, refractory bladder or perineal pain, usually accompanied by frequency and urgency, BPS patients have significantly more pain, sleep dysfunction, anxiety, depression and stress. 6 At present, although various treatments, such as amitriptyline, pentosan polysulfate sodium, hydroxyzine, cyclosporine A, hydroxyzine hydrochloride, tricyclic antidepressants, anticholinergics and intravesical therapy, have been used to relieve the symptoms, the efficacy of these therapies remains unsatisfactory because the therapies have either short-lived effect or long-term benefits accompanied by side effects leading to patient intolerance. 5,7,8 Recently, there has been an increase in the use of complementary and alternative therapies, including electro-acupuncture (EA). 9 Though multiple clinical trials have confirmed the efficacy of EA on a variety of pain conditions, 10–13 studies on the use of EA for BPS are not yet widely conducted. Besides, the reliability within previous trials is still limited against methodological defects, such as small samp -Abstract Truncated-
clinical neurology